Handelsbanken Fonder AB Raises Position in Synopsys, Inc. $SNPS

Handelsbanken Fonder AB boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 4.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 69,814 shares of the semiconductor company’s stock after buying an additional 2,914 shares during the period. Handelsbanken Fonder AB’s holdings in Synopsys were worth $31,142,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Sankala Group LLC purchased a new stake in shares of Synopsys in the 4th quarter valued at about $25,000. Elevation Wealth Partners LLC grew its holdings in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys during the fourth quarter worth about $28,000. IMG Wealth Management Inc. bought a new position in shares of Synopsys in the first quarter worth approximately $30,000. Finally, Atlas Capital Advisors Inc. bought a new position in shares of Synopsys in the fourth quarter worth approximately $32,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Down 0.2%

Shares of SNPS opened at $410.91 on Wednesday. The firm has a market cap of $78.68 billion, a P/E ratio of 95.12, a P/E/G ratio of 2.42 and a beta of 1.23. The stock has a 50 day simple moving average of $429.86 and a two-hundred day simple moving average of $444.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $628.89.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business’s revenue was up 41.9% compared to the same quarter last year. During the same period last year, the firm posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have issued reports on SNPS. Wells Fargo & Company dropped their target price on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating for the company in a research report on Tuesday. Bank of America increased their price target on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Morgan Stanley raised their price objective on shares of Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Benchmark began coverage on shares of Synopsys in a report on Wednesday, July 15th. They set a “buy” rating and a $570.00 price objective for the company. Finally, Berenberg Bank set a $633.00 target price on shares of Synopsys in a research report on Wednesday, May 27th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $565.06.

Insider Activity

In other news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company’s stock.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.